Elpis is interested in forming licensing agreements, partnerships and collaborations in the following areas:

Strategic partnership and collaboration

With biopharmaceutical companies to develop and commercialize pipeline programs

Out-licensing of therapeutics technologies

To enhance partner CAR and NK cell therapy approaches using our armor CAR technology

Discovery collaborations

To identify mono and bispecific antibodies and engineered proteins for partner’s selected targets

Combined therapeutic approaches

With CAR-T, CAR-NK cell therapies, antibody conjugated ADC, radiotherapy, and small molecule combinations

If you are interested in partnering with Elpis, please contact us